Kakleas Konstantinos, Kossyva Lydia, Korona Anastasia, Kafassi Nikolitsa, Karanasios Spyridon, Karavanaki Kyriaki
Diabetic Clinic, 2nd Department of Pediatrics, National and Kapodistrian University of Athens, 'P. & A. Kyriakou' Children's Hospital, Athens, Greece.
Department of Immunology, 'Laiko' General Hospital, Athens, Greece.
Ann Pediatr Endocrinol Metab. 2022 Sep;27(3):192-200. doi: 10.6065/apem.2142168.084. Epub 2021 Nov 15.
Type 1 diabetes mellitus (T1DM) is an autoimmune condition characterised by the presence of antipancreatic antibodies. The autoimmune process is also directed against other organs, most frequently against the thyroid gland, intestinal mucosa, and gastric parietal cells.
Our investigation included 121 children with T1DM with a mean age±standard deviation of 11.99±4.63 years (range, 2.0-20.0 years). We explored the frequency of associated autoimmunity; the presence of predictive factors such as current age, sex, and severity at diabetes diagnosis; T1DM duration; and family history of autoimmunity.
Associated autoimmunity was present in 28.9% of T1DM patients. Children with associated autoimmunity were older at diabetes diagnosis (p=0.009) and had a longer diabetes duration compared to children without associated autoimmunity (p=0.044). Adolescents aged 12-20 years had a statistically significant higher chance of developing thyroid autoimmunity compared to children aged 1-5 years (p=0.019). Multiple autoimmunity (MA), T1DM, and 2 or more autoimmune diseases were present in 5.8% of the study population. All children with MA presented with ketoacidosis at diabetes diagnosis and had a higher percentage of familial autoimmunity (p=0.042). The familial autoimmunity of these patients most frequently affected ≥3 relatives (p=0.026) and was more frequently diagnosed before 5 years of age (p=not significant).
Associated autoimmunity was present in almost one-third of T1DM patients. Significant associations with associated autoimmunity were longer diabetes duration, female sex, older age at diabetes diagnosis, and glutamic acid decarboxylase positivity. Predictors of MA were age <5 years at T1DM diagnosis, the presence of diabetic ketoacidosis at diagnosis, and a significant family history of autoimmunity.
1型糖尿病(T1DM)是一种自身免疫性疾病,其特征是存在抗胰腺抗体。自身免疫过程也针对其他器官,最常见的是针对甲状腺、肠黏膜和胃壁细胞。
我们的研究纳入了121例T1DM儿童,平均年龄±标准差为11.99±4.63岁(范围为2.0 - 20.0岁)。我们探究了相关自身免疫的发生率;糖尿病诊断时的预测因素,如当前年龄、性别和病情严重程度;T1DM病程;以及自身免疫的家族史。
28.9%的T1DM患者存在相关自身免疫。与无相关自身免疫的儿童相比,有相关自身免疫的儿童在糖尿病诊断时年龄更大(p = 0.009),且糖尿病病程更长(p = 0.044)。与1 - 5岁的儿童相比,12 - 20岁的青少年发生甲状腺自身免疫的几率在统计学上显著更高(p = 0.019)。5.8%的研究人群存在多重自身免疫(MA)、T1DM以及2种或更多自身免疫性疾病。所有患有MA的儿童在糖尿病诊断时均出现酮症酸中毒,且家族性自身免疫的比例更高(p = 0.042)。这些患者的家族性自身免疫最常累及≥3名亲属(p = 0.026),且更常在5岁前被诊断出来(p = 无显著差异)。
近三分之一的T1DM患者存在相关自身免疫。与相关自身免疫显著相关的因素包括糖尿病病程更长、女性、糖尿病诊断时年龄更大以及谷氨酸脱羧酶阳性。MA的预测因素为T1DM诊断时年龄<5岁、诊断时存在糖尿病酮症酸中毒以及显著的自身免疫家族史。